Manulife (Manufacturers Life Insurance)
HZNP

Manulife (Manufacturers Life Insurance)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,495
Closed -$520K – 3062
2023
Q3 		$520K Sell
4,495
-42
-0.9% -$4.51K ﹤0.01% 2118
2023
Q2 		$467K Sell
4,537
-111
-2% -$11.7K ﹤0.01% 2086
2023
Q1 		$507K Sell
4,648
-949
-17% -$105K ﹤0.01% 1998
2022
Q4 		$637K Buy
5,597
+39
+0.7% +$3.24K ﹤0.01% 1838
2022
Q3 		$344K Sell
5,558
-119
-2% -$8.31K ﹤0.01% 2214
2022
Q2 		$453K Sell
5,677
-376
-6% -$35.6K ﹤0.01% 2116
2022
Q1 		$637K Buy
6,053
+2,122
+54% +$207K ﹤0.01% 2029
2021
Q4 		$424 Hold
3,931
– – ﹤0.01% 2377
2021
Q3 		$431K Hold
3,931
– – ﹤0.01% 2404
2021
Q2 		$368K Hold
3,931
– – ﹤0.01% 2650
2021
Q1 		$362K Hold
3,931
– – ﹤0.01% 2490
2020
Q4 		$288K Hold
3,931
– – ﹤0.01% 2542
2020
Q3 		$305K Hold
3,931
– – ﹤0.01% 2290
2020
Q2 		$217K Buy
+3,931
New +$168K ﹤0.01% 2458
2019
Q2 		– Sell
-116,634
Closed -$3.08M – 3010
2019
Q1 		$3.08M Buy
116,634
+3,658
+3% +$86.7K ﹤0.01% 1332
2018
Q4 		$2.21M Buy
112,976
+6,096
+6% +$119K ﹤0.01% 1363
2018
Q3 		$2.09M Sell
106,880
-15,104
-12% -$287K ﹤0.01% 1449
2018
Q2 		$2.02M Buy
121,984
+860
+0.7% +$13.1K ﹤0.01% 1491
2018
Q1 		$1.72M Sell
121,124
-3,272
-3% -$48.3K ﹤0.01% 1552
2017
Q4 		$1.82M Buy
124,396
+418
+0.3% +$5.87K ﹤0.01% 1528
2017
Q3 		$1.57M Sell
123,978
-1,955
-2% -$24.9K ﹤0.01% 1544
2017
Q2 		$1.5M Buy
125,933
+1,379
+1% +$17.2K ﹤0.01% 1585
2017
Q1 		$1.84M Buy
124,554
+14,922
+14% +$242K ﹤0.01% 1441
2016
Q4 		$1.77M Buy
109,632
+429
+0.4% +$7.78K ﹤0.01% 1414
2016
Q3 		$1.98M Buy
109,203
+356
+0.3% +$6.96K ﹤0.01% 1378
2016
Q2 		$1.79M Buy
108,847
+104,353
+2,322% +$1.69M ﹤0.01% 1386
2016
Q1 		$72K Buy
4,494
+356
+9% +$6.23K ﹤0.01% 3192
2015
Q4 		$90 Hold
4,138
– – ﹤0.01% 3123
2015
Q3 		$82 Sell
4,138
-32
-0.8% -$1.01K ﹤0.01% 3205
2015
Q2 		$145 Sell
4,170
-39,886
-91% -$1.22M ﹤0.01% 3134
2015
Q1 		$1.14K Buy
44,056
+1,489
+3% +$27.3K ﹤0.01% 1606
2014
Q4 		$549 Sell
42,567
-374
-0.9% -$4.68K ﹤0.01% 1920
2014
Q3 		$527 Buy
42,941
+1,475
+4% +$17.1K ﹤0.01% 1961
2014
Q2 		$656K Buy
41,466
+1,856
+5% +$26.5K ﹤0.01% 1857
2014
Q1 		$599 Sell
39,610
-2,565
-6% -$29K ﹤0.01% 1955
2013
Q4 		$322 Buy
42,175
+7,919
+23% +$42.7K ﹤0.01% 2365
2013
Q3 		$115 Sell
34,256
-11,966
-26% -$31.6K ﹤0.01% 2995
2013
Q2 		$114K Buy
+46,222
New +$111K ﹤0.01% 2965

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HZNP Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,495 shares — an estimated $520K sold.

Manulife (Manufacturers Life Insurance) first reported a position in HZNP in Q2 2013 and held it in 38 quarters. The position peaked at $3.08M in Q1 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 4,495 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $520K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 38 quarters.
  • Manulife (Manufacturers Life Insurance)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.08M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.